deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT05084027

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen Prior to Allogeneic Hematopoietic Stem Cell Transplantation for Older Patients With Hematologic Malignancies

Sponsor: First Affiliated Hospital of Wenzhou Medical University

Conditions Allogeneic Hematopoietic Stem Cell Transplantation Hematologic Malignancy Older Patients
Interventions venetoclax combining with fludarabine and melphalan
Updated 6 times since 2021 Last updated: Oct 20, 2021 Started: Oct 7, 2021 Primary completion: Sep 30, 2022 Completion: Sep 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05084027, this PHASE2 trial focuses on Allogeneic Hematopoietic Stem Cell Transplantation and Hematologic Malignancy and remains ongoing. Sponsored by First Affiliated Hospital of Wenzhou Medical University, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Nov 2021 – ~Sep 2022 · 10 months · monthly snapshotRecruiting~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – present · 20 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Nov 2024 — Present [monthly]

    Unknown PHASE2

    Status: Recruiting → Unknown

  2. Sep 2024 — Nov 2024 [monthly]

    Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  4. Nov 2022 — Jul 2024 [monthly]

    Recruiting PHASE2

  5. Sep 2022 — Nov 2022 [monthly]

    Recruiting PHASE2

▶ Show 1 earlier version

  1. Nov 2021 — Sep 2022 [monthly]

    Recruiting PHASE2

    First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • First Affiliated Hospital of Wenzhou Medical University
  • First Affiliated Hospital of Zhejiang University
  • Ningbo Hospital of Zhejiang University
  • Second Affiliated Hospital, School of Medicine, Zhejiang University
  • Sir Run Run Shaw Hospital
  • The Affiliated People's Hospital of Ningbo University
  • The First Affiliated Hospital of Zhejiang Chinese Medical University
  • Zhejiang Provincial People's Hospital
Data source: First Affiliated Hospital of Zhejiang University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations